QMS Medical Allied Services cash flow

Latest FY26

Cash from operations: ₹19.4cr−3.4% on FY25
Capital spending: ₹5.8cr−88.0% on FY25
Free cash flow: ₹13.7cr−₹28.2 cr in FY25
Cash from financing: ₹1.1cr−95.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025

Adjustments to reconcile profit — non-cash items
	—	3.9	3.8
	—	5.9	0.0
	—	0.0	−0.3
	—	−1.1	0.0
Changes in working capital
	—	−6.6	−1.7
	—	−9.4	−0.0
	—	−3.6	−7.0
	—	1.5	−4.8
	—	18.3	17.1
	—	−1.3	0.0
	—	−1.1	3.5
Cash from operating activities
	26.3	16.4	18.7
	—	7.7	7.1
	—	24.1	25.7
	—	0.0	0.0
	—	4.7	5.6
	—	19.4	20.1
	—	19.4	20.1
Cash from investing activities
	—	5.8	0.0
	—	0.0	48.3
	—	0.0	0.1
	—	14.5	0.0
	—	0.0	3.4
	—	1.1	2.7
	—	−1.1	3.5
	—	−20.4	−45.5
	—	−20.4	−45.5
Cash from financing activities
	—	10.4	0.0
	—	0.0	44.4
	—	2.5	15.4
	—	5.9	2.3
	—	0.9	0.9
	—	1.1	25.9
	—	1.1	25.9
	—	0.1	0.5
	—	0.1	0.5
Reference items
	40.9	25.9	25.4
	15.3%	15.0%	16.3%
	13.7	13.7	−28.2
	₹7.06	₹7.06	−₹14.59
	25.19×	—	—
	—	1.63×	1.47×
	—	4.7	5.6
	—	5.9	2.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

QMSMEDI₹177.79

QMS Medical Allied Services Limited

· Pharma & Health

₹ CroreMcap ₹344 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	3.8	3.9	—
+ Finance Costs	0.0	5.9	—
+ Other Non-cash Items	-0.3	0.0	—
+ Other — Cash Effects are Investing / Financing	0.0	-1.1	—
Changes in Working Capital
+ Inventories	-1.7	-6.6	—
+ Trade Receivables	-0.0	-9.4	—
+ Other Current Assets	-7.0	-3.6	—
+ Trade Payables	-4.8	1.5	—
+ Other Current Liabilities	17.1	18.3	—
+ Provisions	0.0	-1.3	—
Total Working Capital Changes	3.5	-1.1	—
Cash from Operating Activities
Profit Before Tax (per I/S)	18.7	16.4	26.3
+ Total Adjustments (incl. Working Capital)	7.1	7.7	—
Cash from Operations (pre-tax)	25.7	24.1	—
+ Other Inflows / (Outflows) — Operating	0.0	0.0	—
+ Income Taxes Paid	5.6	4.7	—
Cash from Operating — before Extraordinary Items	20.1	19.4	—
Cash from Operating Activities	20.1	19.4	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	0.0	5.8	—
+ Acq of Intangible Assets	48.3	0.0	—
+ Disp of Fixed Assets	0.1	0.0	—
+ Purchase of Investments (Equity / Debt)	0.0	14.5	—
+ Payments on Futures / Forwards / Options / Swaps	3.4	0.0	—
+ Interest Received — Investing	2.7	1.1	—
+ Other Inflows / (Outflows) — Investing	3.5	-1.1	—
Cash from Investing — before Extraordinary Items	-45.5	-20.4	—
Cash from Investing Activities	-45.5	-20.4	—
Cash from Financing Activities
+ Proceeds from Issue of Shares (unclassified)	0.0	10.4	—
+ Proceeds from Borrowings	44.4	0.0	—
+ Repayment of Borrowings	15.4	2.5	—
+ Interest Paid	2.3	5.9	—
+ Dividends Paid	0.9	0.9	—
Cash from Financing — before Extraordinary Items	25.9	1.1	—
Cash from Financing Activities	25.9	1.1	—
Net Changes in Cash (pre-FX)	0.5	0.1	—
Net Changes in Cash	0.5	0.1	—
Reference Items
EBITDA	25.4	25.9	40.9
EBITDA Margin %	16.29	14.97	15.33
Free Cash Flow (CFO − Capex)	-28.2	13.7	13.7
Free Cash Flow per Basic Share	-14.59	7.06	7.06
Price to Free Cash Flow	—	—	25.19
Cash Flow to Net Income	1.47	1.63	—
Cash Paid for Taxes	5.6	4.7	—
Cash Paid for Interest	2.3	5.9	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.